Skip to search formSkip to main contentSkip to account menu

dihydrosomatostatin

Known as: somatostatin (15-28) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
N alpha-9-Fluorenylmethyloxycarbonyl (Fmoc) amino acids will be of advantage in solid phase peptide synthesis. The Fmoc-group is… 
2009
2009
Experimental details for practical syntheses of somatostatin and D-Trp8-somatostatin are described. The peptides were assembled… 
1985
1985
High plasma concentrations of C-terminal immunoreactive glucagon (IRG) have been found during early life in several mammalian… 
Highly Cited
1981
1981
1981
To exemplify the usefulness of the S‐tert‐butylthio group for a reversible blocking of the cysteine thiol function in peptide… 
Highly Cited
1980
Highly Cited
1980
Experimental details for the "Fmoc solid phase peptide synthesis" of somatostatin are described. The 9-fluorenylmethyloxycarbonyl… 
Highly Cited
1976
Highly Cited
1976
Somatostatin and dihydrosomatostatin (H2somatostatin) are equipotent in inhibiting insulin and glucagon release induced by… 
Highly Cited
1975
Highly Cited
1975
An in vitro system which uses perifused pieces from the antrum of rat stomach has been used to study the effect of…